| PERIOD ENDING | 31-Jul-09 | 31-Jul-08 | 31-Jul-07 | | Total Revenue | 1,538,610 | 1,877,990 | 2,012,739 | | Cost of Revenue | 1,173,554 | 1,468,784 | 1,615,047 | | | Gross Profit | 365,056 | 409,206 | 397,692 | | | Operating Expenses | | Research Development | 9,035 | 11,567 |
-
| | Selling General and Administrative | 293,667 | 445,979 | 501,658 | | Non Recurring | 78,398 | 35,756 | (11,267) | | Others | 57,415 | 114,250 | 80,011 | | | | Total Operating Expenses | 438,515 | 607,552 |
-
| | | | Operating Income or Loss | (73,459) | (198,346) | (172,710) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (33,466) | (12,543) | 47,049 | | Earnings Before Interest And Taxes | (106,925) | (210,889) | (125,661) | | Interest Expense | 2,656 |
-
|
-
| | Income Before Tax | (109,581) | (210,889) | (125,661) | | Income Tax Expense | (4,521) | 9,923 | 3,605 | | Minority Interest | (1,901) | 1,370 | (10,180) | | | | Net Income From Continuing Ops | (106,961) | (219,442) | (139,446) | | | Non-recurring Events | | Discontinued Operations | (48,488) | (4,888) | 198,070 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (155,449) | (224,330) | 58,624 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($155,449) | ($224,330) | $58,624 |
|
1.48% Nasdaq 0.00%
Income Statement
